- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tamoxifen, Letrozole, Anastrozole or Exemestane
Total 251 results
-
Dana-Farber Cancer InstitutePfizerCompleted
-
Istituto Oncologico Veneto IRCCSUniversity of PadovaCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Institut Cancerologie de l'OuestRecruitingMastectomy | Ductal Carcinoma in Situ | Extensive DiseaseFrance
-
Peking University Cancer Hospital & InstituteRecruiting
-
Fondazione Sandro PitiglianiCompleted
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
International Collaborative Cancer GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; UNICANCERUnknownBreast CancerFrance, Belgium, United Kingdom
-
Cancer Research Campaign Clinical Trials CentreCompletedBreast CancerUnited Kingdom
-
European Organisation for Research and Treatment...CompletedBreast CancerFrance, Thailand, Australia, Belgium, Netherlands, Slovenia, United Kingdom, Malaysia, Poland, Russian Federation, Philippines, Taiwan
-
Institute of Cancer Research, United KingdomUnknown
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States
-
NSABP Foundation IncNational Cancer Institute (NCI); Southwest Oncology Group; North Central Cancer... and other collaboratorsCompletedBreast CancerUnited States, Canada, Puerto Rico
-
Oana DanciuNovartis PharmaceuticalsRecruitingHER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast CancerUnited States
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
wang shusenRecruiting
-
Palleos Healthcare GmbHPfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...Terminated
-
Emory UniversityNovartisTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Nemours Children's ClinicNovartis; Pfizer; AstraZeneca; Genentech, Inc.; Thrasher Research FundCompletedIdiopathic Short StatureUnited States, Chile
-
Novartis PharmaceuticalsSuspendedEarly Breast CancerAustralia
-
ETOP IBCSG Partners FoundationUNICANCER; Danish Breast Cancer Cooperative GroupCompletedBreast CancerFrance, Denmark, Switzerland
-
Jonsson Comprehensive Cancer CenterEli Lilly and CompanyRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial CarcinomaUnited States
-
St Vincent's HospitalRecruitingHormone Receptor Positive Tumor | Early-stage Breast CancerAustralia
-
Dharmais National Cancer Center HospitalCompleted
-
AstraZenecaNot yet recruiting
-
German Breast GroupCompletedBreast Cancer MetastaticGermany
-
Eli Lilly and CompanyActive, not recruitingBreast NeoplasmsUnited States
-
Emory UniversityNational Cancer Institute (NCI); Pfizer; National Institutes of Health (NIH)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Metastatic Breast CarcinomaUnited States
-
Austrian Breast & Colorectal Cancer Study GroupAstraZeneca; Novartis PharmaceuticalsCompletedBreast CancerAustria, Germany
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
University of Colorado, DenverCompletedBreast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
University of California, San FranciscoNovartisCompleted
-
Institut du Cancer de Montpellier - Val d'AurelleCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
German Breast GroupPfizerCompletedMale Breast CancerGermany
-
National Cancer Center, KoreaUnknown
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupActive, not recruitingBreast CancerUnited States, Australia, Switzerland, Italy, Canada, Belgium, Peru, United Kingdom, Egypt, New Zealand, Slovenia, South Africa, Sweden, Hungary, India, Germany, Brazil
-
AstraZenecaCompleted
-
Veru Inc.WithdrawnMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
AstraZenecaCompletedSolid TumoursBelgium, Denmark, France, United Kingdom, Netherlands
-
Instituto Jalisciense de CancerologiaUniversity of GuadalajaraUnknownObesity | Breast Cancer | Nutrition Disorders | Vitamin D Deficiency | Endocrine Therapy | Endocrine Therapy Adverse ReactionMexico
-
Institut Claudius RegaudPHARMACIA SASCompleted
-
NantCell, Inc.CompletedBreast Cancer | Metastatic Cancer | Breast TumorsUnited States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
-
Midwestern Regional Medical CenterUnknownBreast NeoplasmsUnited States